Alumni raised $1.45B in 2022 - Download Free Report Now

AxoGen (NASDAQ: AXGN)

Off-the-shelf implantable allograft tissue to support peripheral nerve repair and regeneration.

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of AxoGen (NASDAQ: AXGN) plus 5517 other startups.

Start Free 7 Day Trial Now

Learn More About AxoGen (NASDAQ: AXGN)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation

Competing Startups

More

Companies We Work With